[ARS] PharmaCyte Biotech, Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

03/09/2026 - 09:40 AM

ARS - PharmaCyte Biotech, Inc.

ARS Filing - PharmaCyte Biotech, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: PharmaCyte Biotech, Inc. (PMCB)

Acceptance Date: 2026-03-09T09:40:00.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Pharmacyte Biotech Inc

NASDAQ:PMCB

View PMCB Stock Overview →

PMCB Rankings

#6557 Ranked by Market Cap

N/A Ranked by Dividends

PMCB Latest News

Nov 25, 2025

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Sep 2, 2025

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Aug 20, 2025

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

Aug 18, 2025

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

May 21, 2024

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

PMCB Latest SEC Filings

Mar 9, 2026

[DEF 14A] PharmaCyte Biotech, Inc. Definitive Proxy Statement

Feb 27, 2026

[PRE 14A] PharmaCyte Biotech, Inc. Preliminary Proxy Statement

Feb 13, 2026

[SCHEDULE 13G/A] PharmaCyte Biotech, Inc. Amended Passive Investment Disclosure

Jan 7, 2026

[Form 4] PharmaCyte Biotech, Inc. Insider Trading Activity

Jan 7, 2026

[Form 4] PharmaCyte Biotech, Inc. Insider Trading Activity

PMCB Stock Data

Market Cap 7.04M

Float 9.77M

Industry Biotechnology

Sector Biological Products, (no Diagnostic Substances)

Website Link

Country United States

City LAS VEGAS